Archives

Archive for January, 2011

Mifepristone III: clouds on the horizon…

In the last quarter century, Psychiatry has undergone a dramatic identity shift, and a big part of that change is the rising prominence of neurobiology and psychopharmacology. Recently, it’s become apparent that the pharmaceutical industry has been a big player in that transition. So we’re becoming used to hearing about clandestine advertising through paid speaker’s […]

Mifepristone II: the “wonder years”…

In December, the Phase 3 results for Corlux for the treatment of Cushing’s Syndrome are due out and investors have been showing an appetite for the stock as of late. This was evidenced by the unusual volume on Friday, which was a half-day for the equity markets. “Approximately 710,100 shares changed hands, a 970.6 percent […]

Mifepristone I: the outer layer…

The story of Alan Schatzberg, Mifepristone, Stanford Medical School, and Corcept described below [Mifepristone 0: $tanford’s $chatzberg redux…] is a multi-layered saga hardly covered by the NIMH’s decision to scrap a study in 2009 – "but we’re done with the mifeprestone aspect." By now, we’re used to stories where the Pharmaceutical Industry wrapped its fingers […]

Mifepristone 0: $tanford’s $chatzberg redux

Dr. Alan Schatzberg was Chairman of Psychiatry at Stanford [1991-2010], coeditor of the book Psychopharmacology, and recent past-President of the American Psychiatric Association. From 1998 through 2008, he was the Principle Investigator on NIMH grants studying the use of MIFEPRISTONE [RU-486] in the treatment of Psychiatric Disorders – primarily Psychotic Depression. The relationship between the […]

treating symptoms and causing diseases…

Atypical Antipsychotics Overprescribed by U.S. Doctors: Study AboutLawsuits.com News and Information about Personal Injury Lawsuits January 10th, 2011 More than half of all prescriptions for newer, atypical antipsychotics, such as Seroquel, Zyprexa and Risperdal, are given without evidence that the powerful drugs will actually help the patient, according to new research.  A study conducted by […]

the speech…

The end of Obama’s speech: …If this tragedy prompts reflection and debate, as it should, let’s make sure it’s worthy of those we have lost. Let’s make sure it’s not on the usual plane of politics and point scoring and pettiness that drifts away with the next news cycle. The loss of these wonderful people […]

I was wrong…

When the news from Tuscon hit the airways, many people assumed that the shooter was an extremist who was responding to the level of inflammatory political rhetoric. That seems to have been incorrect. The shooter was apparently running on his own motor – a psychotic illness as yet undefined. His response to outside influences, if […]

not subtle…

36-520. Application for evaluation; definition A. Any responsible individual may apply for a court-ordered evaluation of a person who is alleged to be, as a result of a mental disorder, a danger to self or to others, persistently or acutely disabled, or gravely disabled and who is unwilling or unable to undergo a voluntary evaluation… […]

ok. I tried…

OK. I tried to watch the speech Sarah Palin read about Tuscon in the video posted everywhere. I couldn’t bring it off. All I could think about was, "No wonder she shoots from the hip instead of having speech-writers." She’s too out of character with a teleprompter. But I did try. Honest. That was the […]

on Seroquel…

I don’t know how widely foodconsumer is read, so I reprinted this article in toto [reformatted to fit your screen]. It should be on the front page of the New York Times because it’s important and because Martha Rosenberg has created such a thorough timeline: Drug Tied to high blood pressure and obesity marketed for […]